UBS Group

UBS Group’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

UBS Group’s Portfolio KNTE Stock Details KNTE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$2.18K	Sell
2023 Q4	$12.1K	Buy
2021 Q4	–	Sell
2021 Q3	$17K	Buy
2021 Q2	$6K	Sell
2021 Q1	$25K	Sell
2020 Q4	$1.59M	Buy